Gilead Sciences
Top View
- First Name Last Name Disclosure Enass Abdel-Hameed Nothing To
- Biogen and Gilead Top Tables with Most Valuable R&D Assets
- C.A. No. 2020-0132-KSJM ) GILEAD SCIENCES, INC., ) ) Defendant
- CSG Associates Entertainment Software Association Ewing Marion Kauffman Foundation 1-800 Contacts, Inc
- Vertex Pharmaceuticals Incorporated
- Faculty Disclosure
- Gilead Sciences Appoints Flavius Martin, MD As Executive Vice President, Research
- Case 1:15-Cv-00760-SLR Document 33 Filed 01/26/16 Page 1 of 18 Pageid #: 641
- Gilead Sciences Inc.: Roche's Daniel O'day to Be
- EMTRIVA® (Emtricitabine) Capsule, for Oral Use 200 Mg 200 Mg 200 Mg EMTRIVA® (Emtricitabine) Oral Solution Capsule 200 Mg Every Every Every Initial U.S
- J&J New Gilead Deal Could Spark Even More Combinations In
- Mylan Launches Gilead Sciences' Sovaldi® Tablets in India
- Faculty Disclosures
- 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
- Company Overview Gilead Sciences, Inc
- CFRI's Weekly Summary of News & Events for Our CF Community!
- Gilead Sciences
- Advancing Therapeutics. Improving Lives